A Real-World, International, MultICentre, Non-Interventional, Prospective CoHORt to Assess the Clinical and Patient-Reported Outcomes in Adults with MOderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated with Breztri/Trixeo (Budesonide /Glycopyrronium / Formoterol) in Routine Care Settings

drug protocol number
D5980R0012
drug sponsor
PI initiated
drug study
Budesonide/ Glucopyrronim/ Formoteral
drug trial site
Abha Private Hospital,King Fahad Medical City (Riyadh)
drug status
Ongoing
drug phase